Patents by Inventor Seong Woo Anthony Kang

Seong Woo Anthony Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RAPAMYCIN ANALOGS AND USES THEREOF
    Publication number: 20240139164
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: November 1, 2023
    Publication date: May 2, 2024
    Inventors: David John O'NEILL, Eddine SAIAH, Seong Woo Anthony KANG
  • RAPAMYCIN ANALOGS AND USES THEREOF
    Publication number: 20240131012
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: November 1, 2023
    Publication date: April 25, 2024
    Inventors: David John O'NEILL, Eddine SAIAH, Seong Woo Anthony KANG
  • Rapamycin analogs and uses thereof
    Patent number: 11944605
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: April 2, 2024
    Assignee: Janssen Pharmaceutica NV
    Inventors: Eddine Saiah, David John O'Neill, Seong Woo Anthony Kang
  • Rapamycin analogs and uses thereof
    Patent number: 11819476
    Abstract: The present invention provides compounds of formula I, compositions thereof, and methods of using the same as mTORC1 inhibitors.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: November 21, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang
  • RAPAMYCIN ANALOGS AND USES THEREOF
    Publication number: 20220267352
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: January 24, 2022
    Publication date: August 25, 2022
    Inventors: David John O'NEILL, Eddine SAIAH, Seong Woo Anthony KANG
  • RAPAMYCIN ANALOGS AND USES THEREOF
    Publication number: 20210220339
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: November 25, 2020
    Publication date: July 22, 2021
    Inventors: Eddine SAIAH, David John O'NEILL, Seong Woo Anthony KANG
  • RAPAMYCIN ANALOGS AND USES THEREOF
    Publication number: 20210186935
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: December 4, 2020
    Publication date: June 24, 2021
    Inventors: David John O'NEILL, Eddine SAIAH, Seong Woo Anthony KANG
  • Rapamycin analogs and uses thereof
    Patent number: 10980784
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: April 20, 2021
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Eddine Saiah, David John O'Neill, Seong Woo Anthony Kang
  • Phenyl amino piperidine mTORC inhibitors and uses thereof
    Patent number: 10844013
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: November 24, 2020
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
    Publication number: 20200207716
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: August 7, 2019
    Publication date: July 2, 2020
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • PYRROLE mTORC INHIBITORS AND USES THEREOF
    Publication number: 20190389843
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: November 8, 2017
    Publication date: December 26, 2019
    Applicant: Navitor Pharmaceuticals, Inc.
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • RAPAMYCIN ANALOGS AND USES THEREOF
    Publication number: 20190388401
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: June 17, 2019
    Publication date: December 26, 2019
    Inventors: Eddine Saiah, David John O'Neill, Seong Woo Anthony Kang
  • Phenyl amino piperidine mTORC inhibitors and uses thereof
    Patent number: 10414727
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: September 17, 2019
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
    Publication number: 20180127370
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: November 8, 2017
    Publication date: May 10, 2018
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • Soluble mTOR complexes and modulators thereof
    Patent number: 8889706
    Abstract: The present invention relates to small molecule modulators of mTORC1 and mTORC2, syntheses thereof, and intermediates thereto. Such small molecule modulators are useful in the treatment of proliferative diseases (e.g., benign neoplasms, cancers, inflammatory diseases, autoimmune diseases, diabetic retinopathy) and metabolic diseases. Novel small molecules are provided that inhibit one or more of mTORC1, mTORC2, and PI3K-related proteins. Novel methods of providing soluble mTORC1 and mTORC2 complexes are discussed, as well as methods of using the soluble complexes in a high-throughput manner to screen for inhibitory compounds.
    Type: Grant
    Filed: November 6, 2012
    Date of Patent: November 18, 2014
    Assignees: Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Inc.
    Inventors: Nathanael Gray, Jae Won Chang, Jianming Zhang, Carson C. Thoreen, Seong Woo Anthony Kang, David M. Sabatini, Qingsong Liu
  • Soluble mTOR complexes and modulators thereof
    Patent number: 8394818
    Abstract: The present invention relates to small molecule modulators of mTORC1 and mTORC2, syntheses thereof, and intermediates thereto. Such small molecule modulators are useful in the treatment of proliferative diseases (e.g., benign neoplasms, cancers, inflammatory diseases, autoimmune diseases, diabetic retinopathy) and metabolic diseases. Novel small molecules are provided that inhibit one or more of mTORC1, mTORC2, and PI3K-related proteins. Novel methods of providing soluble mTORC1 and mTORC2 complexes are discussed, as well as methods of using the soluble complexes in a high-throughput manner to screen for inhibitory compounds.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: March 12, 2013
    Assignees: Dana-Farber Cancer Institute, Inc., Whitehead Institute for Biomedical Research
    Inventors: Nathanael Gray, Jae Won Chang, Jianming Zhang, Carson C. Thoreen, Seong Woo Anthony Kang, David M. Sabatini, Qingsong Liu
  • SOLUBLE MTOR COMPLEXES AND MODULATORS THEREOF
    Publication number: 20110288091
    Abstract: The present invention relates to small molecule modulators of mTORC1 and mTORC2, syntheses thereof, and intermediates thereto. Such small molecule modulators are useful in the treatment of proliferative diseases (e.g., benign neoplasms, cancers, inflammatory diseases, autoimmune diseases, diabetic retinopathy) and metabolic diseases. Novel small molecules are provided that inhibit one or more of mTORC1, mTORC2, and PI3K-related proteins. Novel methods of providing soluble mTORC1 and mTORC2 complexes are discussed, as well as methods of using the soluble complexes in a high-throughput manner to screen for inhibitory compounds.
    Type: Application
    Filed: October 16, 2009
    Publication date: November 24, 2011
    Applicants: Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Inc.
    Inventors: Nathanael Gray, Jae Won Chang, Jianming Zhang, Carson C. Thoreen, Seong Woo Anthony Kang, David M. Sabatini, Qingsong Liu